Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/19/1998 | CA2237557A1 Composition base for topical therapeutic and cosmetic preparations |
03/19/1998 | CA2237314A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes |
03/18/1998 | EP0829541A2 Osmo-controlled fermentation process for the preparation of acarbose |
03/18/1998 | EP0829487A2 Polyene antibiotics 3874 H1 to H6, method for their preparation and use |
03/18/1998 | EP0829486A2 Polyene antibiotics, 3874 H1 to H6, method for their preparation and use |
03/18/1998 | EP0829481A1 Morphinan hydroxamic acid compounds |
03/18/1998 | EP0829480A2 Tetrazolyl-substituted quinuclidines as substance P antagonists |
03/18/1998 | EP0829470A1 2-Cyano-3,5-dihydroxy-hex-2-ene carboxamide derivatives, process for their preparation and their use as medicaments |
03/18/1998 | EP0829263A1 Use of 8,9-dehydroestrone in estrogen therapy |
03/18/1998 | EP0829262A2 Use of PKC inhibitors for the manufacture of a medicament for the treatment of sexual dysfunctions |
03/18/1998 | EP0829261A2 Composition comprising isoflavone or derivatives thereof for promoting fat-degradation in fat-cells |
03/18/1998 | EP0829260A1 Use of at least one pyrimidine derivative substituted in position G as stimulant of tyrosinase |
03/18/1998 | EP0828851A2 Tripeptidylpeptidase inhibitors |
03/18/1998 | EP0828849A1 High-affinity oligonucleotide ligands to growth factors |
03/18/1998 | EP0828839A1 Animal gene therapy |
03/18/1998 | EP0828825A1 Methods of use of phthalocyanines to inactivate blood borne parasites |
03/18/1998 | EP0828754A1 Dipeptides which promote release of growth hormone |
03/18/1998 | EP0828750A1 Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide |
03/18/1998 | EP0828746A1 Novel quinoxaline dione derivatives, their production and their use in medicaments |
03/18/1998 | EP0828743A1 Water soluble camptothecin analogs |
03/18/1998 | EP0828742A1 Diazepino-indoles as phosphodiesterase iv inhibitors |
03/18/1998 | EP0828741A1 Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones |
03/18/1998 | EP0828737A1 Isoxazoline and isoxazole derivatives as integrin receptor antagonists |
03/18/1998 | EP0828733A1 Benzopyrans and pharmaceutical compositions containing them |
03/18/1998 | EP0828732A1 Peptidyl compounds and their therapeutic use |
03/18/1998 | EP0828730A1 Piperazine derivatives |
03/18/1998 | EP0828728A1 Phenyl dihydrobenzofuranes |
03/18/1998 | EP0828727A1 Cyclohexyl dihydrobenzofuranes |
03/18/1998 | EP0828726A1 Tricyclic inhibitors of matrix metalloproteinases |
03/18/1998 | EP0828724A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors |
03/18/1998 | EP0828722A1 Process for making heterocyclic compounds |
03/18/1998 | EP0828721A1 2-amino-benzoxazinones for the treatment of viral infections |
03/18/1998 | EP0828715A1 N-oxides as antibacterial agents |
03/18/1998 | EP0828714A1 Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form |
03/18/1998 | EP0828712A1 Beta-adrenergic agonists |
03/18/1998 | EP0828706A1 Amide derivatives and external skin or hair care preparations |
03/18/1998 | EP0828702A1 Process for resolving chiral acids with 1-aminoindan-2-ols |
03/18/1998 | EP0828518A1 Gene transfer for treating a connective tissue of a mammalian host |
03/18/1998 | EP0828515A1 Antibacterial-wound healing compositions and methods for preparing and using same |
03/18/1998 | EP0828514A1 Immunostimulating-wound healing compositions and methods for preparing and using same |
03/18/1998 | EP0828513A2 Combinations for the treatment of parkinsonism containing selective nmda antagonists |
03/18/1998 | EP0828508A2 Compositions of interleukin and pyrimidine nucleosides |
03/18/1998 | EP0828506A2 Endoparasiticidal agents |
03/18/1998 | EP0828502A2 Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field |
03/18/1998 | EP0828500A1 Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast |
03/18/1998 | EP0828498A1 Chemotherapeutic compositions |
03/18/1998 | EP0828497A1 Methods of inhibiting leaderless protein export using cardiac glycosides or aglycones therefrom and derivatives |
03/18/1998 | EP0828496A1 Use of alendronate for the prevention of osteoporosis |
03/18/1998 | EP0828495A1 Stabilized solid dispersions of misoprostol |
03/18/1998 | EP0828494A1 Method for treating cognitive dysfunction |
03/18/1998 | EP0828493A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds |
03/18/1998 | EP0828492A1 Method for preventing intervention-associated stenosis following non-bypass, invasive interventions |
03/18/1998 | EP0828491A1 Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects |
03/18/1998 | EP0828490A1 RAR-beta SELECTIVE RETINOID COMPOUNDS FOR INHIBITING GENE EXPRESSION PROMOTED BY AP1 PROTEIN AND THEIR USE IN THERAPY |
03/18/1998 | EP0828489A1 Smoking cessation treatments using naltrexone and related compounds |
03/18/1998 | EP0828488A1 Isothiazolones |
03/18/1998 | EP0828487A1 Agents for use against parasitic protozoa |
03/18/1998 | EP0828486A1 Use of pyrrolidine derivatives for treating alcoholism |
03/18/1998 | EP0828485A1 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof |
03/18/1998 | EP0828484A1 Use of aryl substituted cyclobutyl alkyl amines for the treatment of obesity |
03/18/1998 | EP0828483A1 Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase |
03/18/1998 | EP0828482A1 Cosmetic make-up compositions |
03/18/1998 | EP0828481A1 Oral dosage composition for intestinal delivery and method of use of the same |
03/18/1998 | EP0828478A1 Osmotic device with delayed activation of drug delivery and complete drug release |
03/18/1998 | EP0828434A1 Fat based food products |
03/18/1998 | EP0828418A1 Inducement of thermotolerance with benzoquinonoid ansamycins |
03/18/1998 | EP0723547A4 Boronated metalloporphyrins and therapeutic methods |
03/18/1998 | EP0681586B1 Oligodeoxynucleotides containing 5-alkyl-, 5-(1-alkenyl)- and 5-(1-alkynyl)pyrimidines and pharmaceutical compositions containing such compounds |
03/18/1998 | EP0674638B1 Substituted triols |
03/18/1998 | EP0674512B1 Application of riluzole in the treatment of neurological lesions related to traumatic injuries |
03/18/1998 | EP0619734B1 New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole |
03/18/1998 | EP0598753B1 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
03/18/1998 | EP0590009B1 Dialkyl (dialkoxyphosphinyl)methyl phosphates as anti-inflammatory agents |
03/18/1998 | EP0544773B1 Azabicyclic compounds, process and intermediates for their preparation and pharmaceutical compositions containing them |
03/18/1998 | EP0506845B1 Uncharged morpholino-based polymers having achiral intersubunit linkages |
03/18/1998 | EP0461225B1 Circumvention of human tumor drug resistance |
03/18/1998 | EP0460232B1 Tumor cell growth inhibitor |
03/18/1998 | CN1176662A Identification of genes |
03/18/1998 | CN1176648A A method of identifying CFTR-binding compounds useful for activating chloride conductance in animal cells |
03/18/1998 | CN1176646A CCK or gastrin modulating 5 -heterocyclic-1, 5-benzodiazepines |
03/18/1998 | CN1176645A Compounds with growth hormone releasing properties |
03/18/1998 | CN1176641A Derivatives of 3-pyrrolidylidene -2 -one -cephalosporines |
03/18/1998 | CN1176640A Inhibitors of microsomal triglyceride transfer protein and mothed |
03/18/1998 | CN1176638A 4-aminotetrahydrobenzisoxazole or-isothiazole compounds |
03/18/1998 | CN1176637A Piperazine-2, 5 -dione derivatives as modulators of multidrug resistance |
03/18/1998 | CN1176602A Ascorbyl-phosphoryl-cholesterol |
03/18/1998 | CN1176601A Quinazolinone-containing pharmaceutical compositions and methods for the use thereof |
03/18/1998 | CN1176600A Method for inhibiting ovarian cancer |
03/18/1998 | CN1176599A Pharmaceutical composition for piperidinoalkanol compounds |
03/18/1998 | CN1176598A Method and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
03/18/1998 | CN1176597A Benzothiopyranoindazoles antitumor agents |
03/18/1998 | CN1176596A Parenteral pharmaceutical compositions containing ammoniumalkyl salts of 2-arylpropionic acids |
03/18/1998 | CN1176252A Novel coumarin quinolone carboxylic acids and processes for preparation thereof |
03/18/1998 | CN1176250A HIV protease inhibitors useful for treatment of AIDS |
03/18/1998 | CN1176248A Restricted 9-CIS-retinoids |
03/18/1998 | CN1176138A The use of (meth) acrylic acid/maleic acid copolymers for improving mucosal permeability |
03/18/1998 | CN1176122A External use drug made of hops and vegetable oil |
03/18/1998 | CN1176102A Use of nonpeptide bradykinin antagonists for treatment and prevention of chronic fibrogenetic liver disorders acute liver disorders and complications associated therewith |
03/18/1998 | CN1176101A N -(4 -aryl -thiazol -2 -yl) -sulphonamide derivatives and their use |
03/18/1998 | CN1037774C Phosphonooxymethyl ethers derivatives of taxane |